Skip to main content
Equibles
XRN logo

XRN · Chiron Real Estate Inc.

Track XRN — free

Use XRN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$36.96 +0.44 (+1.20%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$483.45M
Shares
13.24M

XRN metrics

60 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$36.96
Market cap
$483.45M

Price action

19 metrics
Price change (1W)
+0.4%
Price change (30D)
+4.2%
Price change (3M)
+3.0%
Price change (6M)
+3.4%
Price change (YTD)
+9.5%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
29.6%
Beta
0.4
RSI (14D)
52.5
Price vs SMA 50
+0.4%
Price vs SMA 200
+4.5%
Avg volume (3M)
96,235
Relative volume
1.0
Average dollar volume
$3.52M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
13.24M

Valuation

12 metrics
P / E (TTM)
10.0
Trailing earnings · reciprocal yield 10.0%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.2×
reciprocal yield 31.7%
P / book
0.7
reciprocal yield 135.9%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
6.4
reciprocal yield 15.5%
Earnings yield
13.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.6×
reciprocal yield 28.0%
EV / revenue historical average (5Y)
3.6×
reciprocal yield 28.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
7.4%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$2.73
Dividend growth YoY
-86.0%
Dividend growth streak
—
Last ex-dividend
2026-08-20

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
40.9%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$62.73M
Trailing 12 months
Diluted EPS (TTM)
$3.71
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$34.52

Growth

11 metrics
Revenue growth YoY
+4.7%
Year over year
Net income growth YoY
+12,255.7%
Revenue (TTM)
$153.43M
Trailing 12 months
EPS growth YoY
-1,616.7%
Shares change YoY
-1.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.6%
Revenue CAGR (5Y)
+9.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
9.5%
Return on assets
4.6%
Debt / equity
—
Current ratio
0.2
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$10.66M
Total assets
$1.37B
Total debt
$1.15M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$75.11M
Capital expenditures (TTM)
$88.85M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$5.22M
R&D / revenue
—
Stock compensation / revenue
3.4%

Ownership (13F)

3 metrics
13F filers
171
13F filer change QoQ
+9
Institutional ownership
75.5%

Short interest

3 metrics
Short interest
6.5%
Latest settlement · 7.6 days to cover
Days to cover
7.6d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
$2.58M
Insider-sentiment score
95 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1533615 CUSIP 37954A303 13F (30d) 115 filings 115 filers Visit website Investor relations